Selection of data sets for FAIRification in drug discovery and development: Which, why, and how?
- DOI
- 10.1016/j.drudis.2022.05.010this
- Published
- 2022-08
- Container
- Drug Discovery Today
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.drudis.2022.05.010this,
title = {Selection of data sets for FAIRification in drug discovery and development: Which, why, and how?},
author = {Ebtisam Alharbi and Yojana Gadiya and David Henderson and Andrea Zaliani and Alejandra Delfin-Rossaro and Anne Cambon-Thomsen and Manfred Kohler and Gesa Witt and Danielle Welter and Nick Juty and Caroline Jay and Ola Engkvist and Carole Goble and Dorothy S Reilly and Venkata Satagopam and Vassilios Ioannidis and Wei Gu and Philip Gribbon},
year = {2022},
journal = {Drug Discovery Today},
doi = {10.1016/j.drudis.2022.05.010this},
url = {https://doi.org/10.1016/j.drudis.2022.05.010this}
}RIS
TY - JOUR TI - Selection of data sets for FAIRification in drug discovery and development: Which, why, and how? AU - Ebtisam Alharbi AU - Yojana Gadiya AU - David Henderson AU - Andrea Zaliani AU - Alejandra Delfin-Rossaro AU - Anne Cambon-Thomsen AU - Manfred Kohler AU - Gesa Witt AU - Danielle Welter AU - Nick Juty AU - Caroline Jay AU - Ola Engkvist AU - Carole Goble AU - Dorothy S Reilly AU - Venkata Satagopam AU - Vassilios Ioannidis AU - Wei Gu AU - Philip Gribbon PY - 2022 JO - Drug Discovery Today DO - 10.1016/j.drudis.2022.05.010this UR - https://doi.org/10.1016/j.drudis.2022.05.010this ER -
APA
Alharbi, E., Gadiya, Y., Henderson, D., Zaliani, A., Delfin-Rossaro, A., Cambon-Thomsen, A., Kohler, M., Witt, G., Welter, D., Juty, N., Jay, C., Engkvist, O., Goble, C., Reilly, D. S., Satagopam, V., Ioannidis, V., Gu, W., & Gribbon, P. (2022). Selection of data sets for FAIRification in drug discovery and development: Which, why, and how?. Drug Discovery Today. https://doi.org/10.1016/j.drudis.2022.05.010this
Source records
- hal · retrieved 2026-09-25T18:46:51.058Z